TABLE 3.
β-H/C activity |
|||
---|---|---|---|
Hemolytic titera | Change in hemolytic titer | Change in cylE transcriptionb | |
-fold | -fold | ||
A909 (WT) | 4 | NAc | 1 |
ΔcylE | <1 | >0.25 | NA |
Δstp1 | <1 | >0.25 | 0.92 ± 0.1 |
ΔcovR | 128 | 32 | 11 ± 0.2 |
ΔcovRΔstp1 | 32 | 8 | 11 ± 0.13 |
a Hemolytic titers were estimated as described (39, 59). The experiment was performed in triplicate, and changes that are >2-fold compared with WT GBS A909 are considered significant.
b qRT-PCR was performed as described under “Experimental Procedures.” Gene expression is denoted as -fold difference relative to the WT GBS strain A909. S.E. is indicated.
c NA, not applicable.